MedTrace Logo

The Efficacy of the Cupola Ultrasonic Tattoo Removal Device

NCT01516034 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2012-12-21

Study results available
· View outcomes & findings →

Summary

The study is designed to determine the efficacy of the Cupola tattoo removal device for tattoo removal.

Conditions

  • Tattooing

Interventions

DEVICE

Cupola Tattoo Removal device

Up to 6 treatments with the device every 2-3 weeks to the tattoo area.

Sponsors & Collaborators

  • Cupola Medical Ltd

    lead INDUSTRY

Principal Investigators

  • David J Friedman, M.D. · Friedman Skin & Laser Center

  • Lilach Gavish, Ph.D. · Friedman Skin & Laser Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01516034 on ClinicalTrials.gov